Beacon Biosignals is unlocking the power of brain data to advance human health. The company combines FDA-cleared wearable EEG technology with advanced AI to capture and analyze real-world neural data, enabling breakthroughs across neurology, psychiatry, and sleep medicine. The Beacon Platform provides clinicians and biopharma partners with objective measures of brain function that accelerate research, improve diagnostics, and guide new treatments.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/06/26 | $97,000,000 | Series B |
JSL Health Capital Kicker Ventures Palo Santo VC Samsung NEXT | undisclosed |